We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Pre-Exposure Prophylaxis and HIV Incidence.
- Authors
Mann, Samuel
- Abstract
Pre-Exposure Prophylaxis (PrEP) is a drug that, as demonstrated in clinical trials, when taken makes the user virtually immune to HIV. This has led to numerous countries making the drug available, but little is known about the population level effects of PrEP. Using panel data from 40 European countries I study the effect of countries adopting WHO recommendations to make PrEP available to citizens. I demonstrate that PrEP availability leads to around 15–20 % fewer new HIV infections. My results indicate that PrEP can be an effective tool in reducing HIV incidence.
- Subjects
PRE-exposure prophylaxis; HIV; HIV infections; CITIZENS; EXPOSURE therapy; CLINICAL trials
- Publication
B.E. Journal of Economic Analysis & Policy, 2023, Vol 23, Issue 4, p1163
- ISSN
2194-6108
- Publication type
Article
- DOI
10.1515/bejeap-2023-0087